Kaplan and Sadocks Comprehensive Textbook of Psychiatry, 11e

xxxi

Contributors

John D. Elsworth, Ph.D. Senior Research Scientist, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 1.7 Biogenic Amine Neurotransmitters Steven A. Epstein, M.D. Physician Executive Director/ Professor, Department of Psychiatry, MedStar Health/ Georgetown University School of Medicine, Washington, DC 27.1 History and Current Trends David Erritzoe, M.D., Ph.D., M.R.C.Psych. Clinical Senior Lecturer and Consultant Psychiatrist, Centres for Neuropsychopharmacology and Psychedelic Research, Department of Brain Sciences, Division of Psychiatry, Imperial College London, London, United Kingdom 33.14b MDMA, Psilocybin, Ayahuasca, and Ibogaine Rodrigo Escalona, M.D. Professor and Attending Psychiatrist, Department of Psychiatry and Behavioral Sciences, University of New Mexico School of Medicine and New Mexico VA Health Care System, Albuquerque, New Mexico 12.2 Phenomenology of Schizophrenia Javier I. Escobar, M.D., M.Sc. Professor Emeritus, Departments of Psychiatry and Family Medicine, Rutgers University, Robert Wood Johnson Medical School, Piscataway, New Jersey; Professor, Departments of Psychiatry and Health Humanities and Society, Florida International University, Herbert Wertheim College of Medicine, Miami, Florida; Associate Dean for Global Health, Office of Global Health, Rutgers University, Robert Wood Johnson Medical School, Piscataway, New Jersey 9.1 Present and Future of Classification Systems for Mental Disorders, 9.2 The Classification of Mental Disorders in the International Classification of Diseases (ICD-11), 18 Somatic Symptom and Related Disorders Zelde Espinel, M.D., M.P.H. Assistant Professor of Psychiatry, Psychiatry and Behavioral Sciences, University of Miami Leonard M Miller School of Medicine, Miami, Florida 33.11b Cholinesterase Inhibitors and Memantine Spencer Eth, M.D. Professor and Chief of Mental Health, Miami VA Medical Center, University of Miami Leonard M Miller School of Medicine, Miami, Florida 58.1 Clinical-Legal Issues in Psychiatry Harris A. Eyre, M.B.B.S., Ph.D. Fellow in Brain Health, Center for Health and Bioscience, Baker Institute for Public Policy, Rice University, Houston, Texas 55.2b Complementary and Integrative Geriatric Psychiatry Tanya Fabian, Pharm.D., Ph.D. Associate Professor and Director of Pharmacy, Department of Pharmacy and Therapeutics and Psychiatry, University of Pittsburgh, School of Medicine and University of Pittsburgh Medical Center Western Psychiatric Hospital, Pittsburgh, Pennsylvania 10.2 Delirium Nathan Fairman, M.D., M.P.H. Associate Health Sciences Clinical Professor, Department of Psychiatry and Behavioral Sciences, University of California-Davis School of Medicine, Sacramento, California 55.6c Ethical Issues

Lisa B. Dixon, M.D., M.P.H. Edna L Edison Professor of Psychiatry, Department of Psychiatry, Division of Behavioral Health Services and Policy Research, New York State Psychiatric Institute/Columbia University Vagelos College of Physicians and Surgeons, New York, New York 56.4 Mental Health Services Research Robert Lloyd Doyle, M.A., D.D.S., M.D. Assistant Medical Director, Department of Child and Adolescent Inpatient Unit, McLean Hospital, Brighton, Massachusetts 49.2 Stereotypic Movement Disorders in Children Robert E. Drake, M.D., Ph.D. Professor of Clinical Psychiatry, Columbia University, Vagelos College of Physicians and Jack Drescher, M.D. Clinical Professor, Department of Psychiatry, Columbia University, Vagelos College of Physicians and Surgeons, New York, New York 21.2 Homosexuality, Gay and Lesbian Identities, and Homosexual Behavior, 21.4 Gender Identity, Gender Diversity, Gender Dysphoria/Incongruence Steven L. Dubovsky, M.D. Professor and Chair, Department of Psychiatry, University at Buffalo, Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York 33.9a Barbiturates and Similarly Acting Substances, 33.9b Benzodiazepine Receptor Agonists and Antagonists, 33.10a Calcium Channel Inhibitors Jennifer J. Dunkin, Ph.D. Clinical Professor (Voluntary), Department of Psychiatry and Biobehavioral Sciences, University of California, School of Medicine, San Diego, California 55.2d Psychological Changes With Normal Aging Walter Dunn, M.D., Ph.D. Assistant Clinical Professor, Department of Psychiatry, University of California, David Geffen School of Medicine, Los Angeles, California 33.2b Dopamine-Serotonin Antagonists, 33.3a Dopamine Partial Agonists Dino Dvorak, Ph.D. Postdoctoral Fellow; Senior Director, Data Science and Platform Technologies, Center for Neural Science, New York University, Grossman School of Medicine; Gilgamesh Pharmaceuticals Inc , New York, New York 1.23 Basic Systems Neuroscience Zabrina Ebert, D.O. Chief Resident, Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin Affiliated Hospitals, Milwaukee, Wisconsin 32.17 Acceptance and Commitment Therapy Helen Link Egger, M.D. Chief Medical Officer, Little Otter Health; Adjunct Associate Professor at Duke University, School of Medicine/Duke University Medical Center, Department of Psychiatry and Behavioral Sciences, Durham, North Carolina 35.2 Psychiatric Assessment of Preschool Children Stuart J. Eisendrath, M.D. Professor of Psychiatry Emeritus, Department of Psychiatry, University of California, School of Medicine, San Francisco, California 19 Factitious Disorder Surgeons, New York, New York 12.13 Psychiatric Rehabilitation

Copyright © 2025 Wolters Kluwer, Inc. Unauthorized reproduction of this content is prohibited.